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What are miRNAs and why study miRNAs
2
• A single miRNA has been estimated to regulate up to 500 mRNAs.
• miRNAs are 22nt 
• Due to the size and stability of the miRNAs, it can float freely in the blood.
• miRNAs are now known to be involved in all aspects of diseases.
• miRNA are not only found in mammals, but everything else living: plants, 
microbes, fish,  C. Elegans, fruit flies, insects, etc…
• miRNAs play a big role in radiation response (which also relates to space 
radiation). Silva, S.S., et al., Forensic miRNA: potential biomarker for 
body fluids? Forensic Sci Int Genet, 2015. 14: p. 1-10.
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Systems Biology View of miRNAs
Figure from Vanderburg and Beheshti, MicroRNAs (miRNAs), the Final Frontier: The Hidden Master Regulators 





Systems Biology View of miRNAs 
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Systems Biology Approach: Looking at how the 
most important miRNAs impact the entire system 
miRNAs Associated_with . miRNAs Associated with 
Decreased Health Risk Increased Health Risk 
Systems Biology Approach to Study the Impact of miRNAs




Impact of Circulating microRNAs
Profiling of circulating microRNAs: from single biomarkers to re-wired networks 
Anna Zampetaki, Peter Willeit, Ignat Drozdov, Stefan Kiechl, Manuel Mayr. 
Cardiovascular Research , 2011.
• Circulating miRNAs can carry signals 
from organs to other various parts of 
the body through the blood stream.
• The miRNAs can be transported in 
Exosomes, microparticles, 
lipoproteins, and outside any type of 
packaging.
• miRNAs can be conserved across 
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Determining miRNA signature associated with diseases: 
Lymphoma
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Abstract 
Extensive epidemiological data have demonstrated an exponential rise in the incidence of 
non-Hodgkin lymphoma (NHL) that is associated with increasing age. The molecular etiol-
ogy of this remains largely unknown, which impacts the effectiveness of treatment for 
patients. We proposed that age-dependent circulating microRNA (mi RNA) signatures in the 
host influence diffuse large B cell lymphoma (DLBCL) development. Our objective was to 
examine tumor development in an age-based DLBCL system using an inventive systems 








Determining miRNA signature associated with diseases: 
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Smurf2-deficient Mice vs Wild-Type 
Mice: 2 months old 
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Through ddPCR we are able to get exact counts of circulating miRNA in the serum 
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Identification of Circulating Serum 
Multi-MicroRNA Signatures in 
Human DLBCL Models 
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Conclusion Part 1: DLBCL miRNA Signature
Charles 
VanderburgDavid WeinstockAndrew Evens Hong Zhang
J. Tyson
McDonald
• This DLBCL miRNA Signature can potentially 
be utilized as a novel liquid biomarker to 
detect onset of DLBCL before any existing 
technology
• This DLBCL miRNA signature can be used to 
monitor patients after treatment to test true 
remission rate of cancer
• Apply same techniques for other cancers to 
determine specific miRNA signature for each 
cancer type.
• Possible miRNA-based therapeutic
A) 
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PERSPECTIVE OPEN 
From the bench to exploration medicine: NASA li fe sciences 
translational research for human exploration and habitation 
missions 
ua S. Alwood1. April E. Ronau, Richard C. Mains1, Mark J. Shelhamer•, Jeffrey 0 . Smith' and Thomas J. Goodwin 5 
NASA's Sl)Ke Biology and Human Research Program emitiH hive recently spearheaded communk.11ions bolh lrnemally and 
externally to COO<dln11te 1he agency's 1ranslatlonal ,_arch effOJts. In 1hls paper, we strongly ldvoc•te fo, translational research at 
NASA. provide recent eumpies of NASA sponsored early-stage translational research, and discuss options for a path forward. Our 
overall ob;ective is 10 help in stimulating a collaborative research acrou muhiple disciplines and entities that. wofking together, wil l 
more effeaively iNld more rilpidly achieve NASA's goals for human §pcl(eHight. 
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Space Environment Health Risks On Astronauts
Select health effects due to space radiation 
exposures.
From: J. Chancellor et al., Space Radiation: The Number One Risk to 
Astronaut Health beyond Low Earth Orbit. Life, 4(3), 491-510;
FEMALE ASTRONAUT 
Women suffer less from hearing 
loss with advancing age, and do 
not display a bias towards loss 
of heanng In lhe left ear 
Women demonstrate 
a slight bias towards 
accuracy versus 
speed 1n response to 





Struvite kidney stones 
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9 Female astronauts, (to dale) do not exhibit 
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impairment 
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Health effect observed on Earth 
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Health effect observed in space 
• Some male astronauts 
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Degenerative damage to 
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to cancer and genetic 
germline mutations 




Partial Weight Bearing Rat Model
https://www.rutkovelab.org/nasa/
Experiments Done in Space Space Radiation Simulated 
Experiments
Brookhaven National Laboratory
Seward Rutkove Marie Mortreux
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Exploring the Effects of Spaceflight on Mouse Physiology using the Open Access NASA Genelab 
Platform 
Afshin Behesht11, Yasaman Sh1razi-Fard2, Sungshin Choi1, Daniel Berrios3, Samraw1t G. Gebre1, Jonathan M. Galazka2, Sylvain V. Costes2 
1WYLE Lat>s, Space Biosciences Division, NASA Ames Research Center, 2space Biosciences Division, NASA Ames Rese.1rch Center, 3USRA, NASA Ames 
Research Center 
Bech Israel Deaconess 
Medica l Center 
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miRNA Signature Prediction Associated with Space Flight
https://genelab.nasa.gov/
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A microRNA signature and TGF-~1 response 
were identified as the key master regulators 
for spaceflight response 
Afshln Beheshtl1 '""• , Shayonl Raf •, Homer Fogle 1, Daniel Berrlos2 , Sytvaln V. Co11es3• 
1 WYLE, NASAAmeIRosearc:hCanler, Motlell.Field, califomla.,llnitedStalesolAmerica, 2 USAA, NASA 
AmesResea!ChC.,,ter,MontUAlld. Celilomla.lJniledSlatesofAmetlca. 3 NAS.f.AmesAeMa,chCtrller. 
~ Bioteiencel DiYiliOn, Molten Field, Qililomia, United Slatu ot ""-iCII 
o,1 The5elllJChorscontrbs1fldequaly10lhilwor1I.. 
" alshnbehuhtj0,...gov tAB);aytv.nv001tNOraugoy (SVC) 
Abstract 
Translating fundamental biological dtSCOVerles from NASA Space Blology program i'l to 
health risk from space flights has been an ongoing cha6eoge. We propose to use NASA 
Geoelab database 10 gain new knowledge on potential systemic responses to space. Unbi· 
ased systems biology analysis ot transcfl)tornlc data from seven different rodent datasets 
reveals for the first li'ne the existence of potential "master regulators· coordinating a sys-
temic response to microgravity ancVor space raciation with TGF-~ 1 being the most common 
reg.ilator. We hypothesized the space environment leads to the release of biomolecules cir-
culating inside the bloOd stream. Through datamlnlng we ldentitJBd 13 candidate mlcroANAs 
(miANA) which are common n al stucies and directly Interact with TGF-131 thal can be 
potential circulatrig !actors i~cting space biology. This study exemplifies the utility ol the 
Genelab data reposito,y to aid in the process of perfooning novel hypothesis-based 
research. 
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Time in Space 









Predicted miRNAs Involved with Spaceflight
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Integration Analysis of MicroRNA and 
mRNA Expression Profiles in Human Peripheral Blood 
Lymphocytes Cultured in Modeled Microgravity 
Hindawi 
C. Girardi,' C. De Pitta,' S. Ca5ara,' E. Cahua,' C. Romualdi,' L Celotti,' •2 and M. Mognato1 
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We analyzed miRNA and mRNA expression profiles in human peripheral blood lymphoq1es (PBLs) incubated in microgra,•ily 
condition, simulated by a ground-based rotating wall vessel (RWV) bioreactor. Our results show that 42 miRNAs were differentially 
expressed in MMC-incubated PBLscomparcd with I g incubated ones. Among these. miR-9-Sp, miR-9-Jp. miR-155-Sp, miR-IS0-
3p, and mlR-378-Jp were the most dysrcgulatcd. To impro\'C the detection of functional miRNA-mRNA pairs. we performed 
gene expression profiles on the same samples assayed for miRNA profiling and we in tegrated miRNA and mRNA expression 
data. The functional classification of miRNA-correlated genes evidenced significant enrichment in the biological processes of 
immune/inflammatory response, signal transduction, regulation of response to stress, regulation of prognmmed cell death, and 
l't'gUlation of cell proliferation. We idenlificd the correlation of miR-9-Jp, miR-ISS..Sp, mlR-1S0-Jp, and miR-378-Jp expression 
with that of genes invoh'e'd Ill immune/inflammatory response (e.g., IFNG and ILl7F), apoptosis (e.g., PDC04 and PTEN). and 
cell proliferation (e.g., NKXJ-1 and GADD45A). Experimental assays of cell viability and apoptosis induction validated the results 
obtained by bioinformatics analyses demonstrating that in human PBLs the exposure to reduced gravitational force increases the 






















Health Risk Due to miRNAs 
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Predict miRNAs with Space Radiation Cardiovascular Risk
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GeneLab Database Analyses Suggest Long-Term 
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Abstract 
Translating fundamentol biolog icol discoveries from NASA Spoce Biology program into 
health risk from space flights has been an ongoing challenge. We propose lo use NASA 
Gene lab database to gain new knowledge on potential systemic responses to space. Unbi· 
ased sys1ems biology analysis of transcriptomic data from seven different rodent datasets 
reveals for the fi rst time the existence of potential "'master regulators- coordinating a sys· 
tomic msponso to microgravity anci/or space radiation With TGF-131 boing the most common 
regulator. We hypothesized the space environment leads to the release of biomolecules cir-
culating inside the blood stream. Through datamining we identified 13 candidate microRNAs 
(miRNA) which are common in all studies and directly interact with TGF-131 that can b8 
potential circulating factors impacting space biology. This study exemplffles the utility of the 






Technique to Quantify miRNAs
Gathered archived 
serum, plasma, and 
serum from various 
collaborators related to 
spaceflight 
experiments
Serum from Patients 
Serum from Mice 
Process & 
~;iii~~~~;. """' . ; Analyze 
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miRNA from Controls 
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miRNA from Experimental Condition 
12000 .,-----,----.--~--.=--~~-~-. 
·- •·• :'J:-,;: >: .:i:.; '' {: i <; :>• Every sing le blue 
· -- · ·· ·· ··· · point on the plots 
1000 .. • 
2000 
represents one 
_ copy of miRNA 
f----~-------
. ( see arrows). 
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f wnlN•fflliN' 
Presence of miRNA signature in Serum of Mice in Simulated 
Space Environment
Significance 
compared to serum 
from Sham NL (Time 
Post IR)
* p-value < 0.05
** p-value < 0.01
*** p-value < 0.001
• Female C57BL/6 mice
• HU for an initial three 
days followed by IR 
and continuation of 
HU for another 1 or 
11 days
• Radiation exposure:  
Total body irradiation 
on conscious mice
• 2Gy Gamma
• 600 MeV/n 56Fe 
(1 Gy and 2 Gy)
• 150 MeV Proton 
(1Gy) 
• ‘1Gy Mix' (0.5Gy 



















p " 0.066 
* 
p-values determined by comparing to 
Sham Normal Loading Conditions, 1 day after IR 
t-SNE Plot: ~ Significant 
miRNAs ~ Only 
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p-values determined by comparing to 
Sham Normal Loading Conditions, 11 days after IR 
• 
D • .. [JI • 
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Irradiation I Sham 2Gy Gamma 
1Gy Proton 
miR- 145- 5p 
miR-17-5p 







Type of Loading 
• Normal Loading 














e 2Gy Gamma 
e 1Gy Proton 
e 1Gy Iron 
e 2Gy Iron 
• 1Gy Mix 
Time Post IR 
e 11 days 
• 1day 
Predicted Targets for the Space Environment miRNA Signature
Circulating miRNA in Serum (Significant miRNAs only) 












i< p = 0.076 
i< 
i< 
miR-21-5p i< i< 
p = 0.089 
i< 
miR-16-5p i< p = 0.093 
i< 
miR-26a-5p i< i< 
i< 
i< 
miR-24-3p i< i< 
-3 -2 -1 0 1 2 3 4 -2 -1 0 1 2 3 
1 Day Post IR 
- HU+1GyMix 
- NL+1GyMix 
- HU+2Gy Gamma 
- NL +2Gy Gamma 
-HU 
11 Days Post IR 
NL+2Gy Iron 
NL+1Gy Iron 





• p-value > 0.05 
•• p-value > 0.01 
••• p-value > 0.001 
5 
Fold-Change (Log2) vs Sham+NL, 1 Day post IR Fold-Change (Log2) vs Sham+NL, 11 days post IR 
A) Top 50 Gene Targets for the miRNA Siganture 
;;~HH:;HH 
~~ii*!~tti;;f 
-o.g-o-o "O"O .g 
ion binding 
organelle 
Fc-epsikm receptor signaling pathway 
molecular function 
neurotrophin TRK receptor signa~ pathway 
~:::~:=~ ~~~~"n,~~~ ;r:e55ic process 
~~c~~~':a~ ~~i~\anscription factor activity 
protein complex 




protein binding transcription factor activity 
catabolic process 
cytosol 
symbiosis, encompassing mutualism through parasitism 
viral process 




response to stress 
nuc1eoplasm 
macromolecular complex assembly 
cell death 
post-translatk>nal protein modification 
~k~~;~rati~~in binding 
cellular lipid metabolic process 
transcription , ONA-templated 
enzyme regulator activity 
axon guidance 
mitotic cell cycle 
cellular protein metabolic process 
membrane organization 
~~:?;f!"~U:l~nrr~~~=~~ ri~;;~~1er 
nervous system development 
fibroblast growth factor receptor signaling pathway 
small molecule metabolic process 
B) Diseases Regulated by the miRNA Signature 
Hepatitis B 
Lysine degradation - 5 
Hippo signaling pathway 
Adherens junc1ion -10 
Proleoglycans in cancer 
~~,~~~ signati"? pathway - 15 
~~~~~~~=~kemia 
Bacterial invasion of epithelial cells 
Thyroid hormone signaling pathway 
Pathways in cancer 
Colorectal cancer 
Fatty acid biosynthesis 
Fatty acid metabolism 
p53 signaling pathway 
ECM-receptor interaction 
• Prion diseases 
Pancreatic cancer 
Prostate cancer 
• Bladder cancer 
Glioma 
;~;;;~;;!!!;! 
~~.g'8;fl,T";"'/Jli»' &fai <r>f' ~ i~~~t~t~it 
Signaling pathways regulating pluripotency of stem cells 
~~:i;~~sis pathway 
Transcription~ misregulatk>n In cancer 
~~~=e~~~:ric:e"n~~r:r'~~siomyopathy (ARVC) 
Small cell lung cancer 
Protein J)(ocessing in endoplasmic reticulum 
~~:~~~ty~~iosynlhesis - keratan sulfate 
Prolactin signaling paifiway 
RNA transport 
~3k~!~f~n~~w;lthway 
Neurotroptun signahng pathway 
~:z~ :e,~~:ay 
Melanoma 
Non-small cell lung cancer 
HTLV-1 infection 
Endocytosis 
MAPK signaling pathway 






miRNAs Decrease with Increasing Gravity Conditions!
Seward Rutkove Marie Mortreux
Partial Weight Bearing Rat Model
https://www.rutkovelab.org/nasa/
B th I rael D aeon s 
Medical Center 
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A) miRNA Signature in Serum from PWB Rats 




























• 20% Gravity 
• 40% Gravity 
70% Gravity 
100% Gravity 
































t-SNE Dimension 1 
C) miRNAs in Serum from PWB Rats 
• miR-34a-5p 
• 15 
.,. • miR-145-5p 





+ • miR-24-3p 
• 
u 


















• • 25 50 75 100 
% Gravity 
D) Circulating miRNAs in Serum of Rats with PWB E) Correlation between miRNAs in serum with muscle data 















-2 -1 0 1 2 
Fold-Change (log2) 
1111 70% vs 100% 
1111 40% vs 100% 
111120% vs 100% 
3 
* p-value < 0.05 
** p-value < 0.01 




,"- ,"3 ,"- )' ,'1.- ,'V ,'V ,'1.- ," ,'1.- ,OJ ,"-,:,_'l>,:,_G Q(:, Q"' ~(:,~O Q(:,R} 
~~ ~~~~~~~~~~ ~~~~~~ ~~ ~~ ~~q,<...._q,<,t.J~C,'l;(:,(J-'l;~(:, .. f'~~ 
miR- 16-Sp • • e O OO O CD e e 0 0 0 e O e OO 
miR-34a-5p • • e e O eO O O e e O 0 
miR-145-Sp e e10 10 e O e 
miR-125b-5p . 0 0 0 0 e e O OO e 
miR-2 1-Sp ··••o CD O • • ... 10 0 0 
miR-26a-5p eo O e O ... 10 e 
miR-24-3p • • e O O O ~0 ,0 0 0 
miR-223-3p . 0 e e @CD. e 0 
miR-17-Sp · · · • 0 0 e O e 
miR-217-Sp e o O CD • 0 • 
miR-92a-3p • O O CD • • • 
miR-146a-5p · • O • • 
let-7a-5p · • • 
let-7c-5p . 0 10 0 0 
triceps mass • 0 CD • • 
biceps mass 1e 
soleus mass • CD e CD 
gastroc mass eCD 












Direct Impact of the miRNAs After Mice Return from Space
• Female BALB/c Mice on the ISS for 
35 days
• Returned to Earth for 4 days before 
being sacrificed
• Approximate accumulated radiation 
dose = 7-9mGy Center for the 






Age 3 3 
Mice 2 Mice 2 Mice 2 
miR-217-5p miR-145-Sp 
, 







miR-145-Sp -4 miR-217-Sp -3 miR-146a-5p -3 
miR-26a-5p 
Age 
Young miR-125b-Sp l miR-26a-5p 
miR-92a-3p Old let-7c-5p miR-92a-3p 
let-7c-5p Mice miR-223-3p l miR-145-Sp 
let- 7a-5p Spaceflight let- 7a-5p miR- 125b-5p 
miR-34a-5p miR-16-Sp miR-24- Jp 
miR- 125b- 5p miR- 17-Sp miR- 34a-5p 
miR-24-3p miR-34a-5p let-7a-5p 
miR-146a-5p miR-26a-5p let-7c-5p 
miR-16-Sp miR-21-Sp 
miR- 21-Sp miR-16- Sp 
miR-17- Sp miR- 17- Sp 
D) miRNAs in Serum from Mice Flown to ISS 
All Mice 
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F) Young Mice 
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t-SNE Dimension 1 
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I-SNE Dimension 1 
• 
After Mice Flown to ISS 
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miR-145-5-p 7e= 0 10 C 
miR-125b-5p e c a> CC ~ ~ =c 
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miR-16-5p e c c 7 C CC C 
miR- 26a- 5p e c C O = = i
miR-24-3p •=o e> OC C 
miR-223-3p • O 
miR-217-5p . + 
miR- 17- 5p . C C:L-
miR- 92a- 3p e + + 
miR-146a-5p -.~ , 
let-7a-5p e a> + ~ 
let-7c-5p e 1 1 
Age (days) e C 0 1 
Flight=1 or Basal=-1 e a> 
Body Weight Change • 
Adrenal Gland Weight • 
Brain Weight e 
Heart Weight e 



























Normalized Adrenal Gland Weight 
. . .. . 







0.00015 0.00020 0.00025 0.00030 
Adrenal Gland Weight 





















. ..Ji,. • ... Iii. 
0.016 0.018 0.020 0.022 
Brain Weight 
Normalized to Body Weight 
Condition 
















Spaceflight miRNAs Relevance to Humans




• Human peripheral blood 
mononuclear cells (PBMCs) were 
irradiated at BNL with 0.3Gy and 
0.82Gy 56Fe.
• PBMCs from different individuals.
• Cells were fixed 4 hrs after 
irradiation.
miRNA data from the NASA Twin Study 
also confirms that this miRNA signature 
does exist in astronauts flown in space!! 
(Unfortunately can’t show results until 
getting final approvals from NASA)
dJ<lJ Space 
G 't,~ Biosciences 
• "" '"" ""''"°" """" 
















































• Underweight (BM l<18.5) 
Correlation between miRNAs with PBMC 
Cell Changes 4 hours after IR t -~ ~ ~ ~~~ • Normal Weight (BMl=18.5-24.9) 
Overweight (BMl=25-29.9) 
Obesity (BMI > 29.9) 
~~p~~~~~~~~p ~~~ ~~~pp~~~p~~~~~§ Ji~ 
Age 
20-29 years old 
30-39 years old 
40-49 years old 
50-59 years old 
60-69 years old 
Sample ID 
1 Dose (Gy) 
2 10.00 0.30 
0.82 
~~~~~~~~~~~~/ ,~~ 0rr,& 
/ / I I I I I I I I I I J\...'11 /\...C., <lJ fl ,.._ ;t <l.>f}; 
ttttttttttttJJQ!J~f,Jcfftfo\~ 
miR-34a-5p • 0 0 i 0 
miR-145-Sp e o i:UiCOOO CCC O 
miR-125b-5p • -~ 0 00 0 C OO~ 
miR-21-Sp e CCOCO 0 000 
miR-16-Sp e C000 OCCC 
miR-26a-5p e CCC OCOC 
miR-24-3p • •• OCOC 
miR-223-3p • • OCCC 
miR- 17-Sp • L1ccoc 
miR-217-Sp . 
miR-92a-3p e CCO 











let-7a- 5p ec 










































PBMC Cell Numbers • 0 
% Dead Cells e o 





Samples: 1, 2, 4, 5, 6 Samples: 3, 7, 8, 9, 10, 11 , 12 
All Samples (lower BMI Females) (higher BMI Males & Females) 
• p.vatue < 0.05 
•• p-value < 0.01 




























2 3 4 -2 -1 0 1 2 3 4 -2 -1 0 1 2 3 4 
Fold-Change (log, ) 
Conclusion part 2: General Spaceflight miRNA Signature Can Be 
Utilized for Monitoring Spaceflight Health Risks
This spaceflight associated 
miRNA signature can be a 
novel minimally invasive 
biomarker to monitor 
increased health risks for 
long-term space missions
Health Risk Due to miRNAs 
• Predicted Activation 
• Predicted Inhibition 
HR = •12. 9 
C) Negative Impact on Health 
C) Positive Impact on Health 
O Both Positive and Negative Impact 
FEMALE ASTRONAUT 
Women suffer less from hearing 
loss wijh advancing age, and do 
not display a bias towards loss 
of heanng In the left ear 
Women demonstrate 
a slight bias towards 
accuracy versus 
speed ,n response to 





Struvite kidney stones 
more common In women 
9 Female astronauts, (to date) do not exhibtt 
clinica lly significant visual 
impairment 
Female astronauts are 
more susceptible to 
orthostat lc Intolerance 
Urinary tract 
infections are 
more common In 
female astronauts 
Large individual 
variabilijy to muscle 
and bone loss In 
Health effect observed on Earth 
Men suffer more from hearing 
loss with advancing age, and 
display a bias towards loss of 
hearing in the left ear 
Men demonstrate a 
slight bias towards 
speed versus accuracy 
In response to an 
a1enness test 
Men mount less 
potent Immune 
responses 
Calcium oxalate kidney 




Health effect observed in space 
Some male astronauts 
exhibij clinically significant 
visual impairment 
Male astronauts 




common in male 
astronauts 
Large individual 
vanablllty to muscle 
and bone loss in men 
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Appendix G: Solicitation of 
Proposals for Flight and 









































Seward Rutkove Marie Mortreux
PWB samples
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Operating in the Lunar 
· Vicinity (proving· grou·nd) 
Phase -0 
Continue· research and • 
testing on ISS to solve 
exploration challenges. 
Evaluate potential ·for 
lunar resources., 
Devel op standards_. 
Phase -1 
Begin missions in · 
cislunar space·." Build 
Deep· Space Gateway. 
Initiate assembly of . . 
Deep Space Transport. 
"After 2030 
Leaving the Earth-Moon System 
and Reaching Mars Orb~t 






Phases 3 and 4 
B~gin sustained 
crew expeditions 
to Martian system 
and ·surface of 
Mars. 
Determining Deep Space miRNA signature Associated with 
Cardiovascular Health Risks
SLPSRA 
Galactic cosmic r~ys 
(H, He--Fe--nuclei •• _ •.. ) -
- . - -- --- -- ---·-·--··---
------- - --------- - -
/ 




SPECIFIC AIM 1: To determine the impact and mechanisms of circulating miRNA signatures that drive microvascular disease and muscle 
degeneration associated with and without space irradiation and simulated microgravity
SPECIFIC AIM 2: Establish functional significance and develop countermeasure strategies for circulating miRNAs and signaling pathways 
associated with microvascular disease and muscle degeneration with space irradiation and simulated microgravity (SMG).
Specific Aim 1: Identify Key miRNA Signature
Specific Aim 2: Utilize 3D microvascular
tissue models to determine functional
impact of miRNAs and start development
of miRNA based countermeasures with
both in vitro and in vivo models.
Determining Deep Space miRNA signature Associated with 
Cardiovascular Health Risks
Peter Grabham
Total of N=10 mice 
per control group 
Collect Blood 
0.5Gy GCR Sim Model 
')dPCR i,, i,, i,, i,, 
Total of N=10 mice per 
hindlimb suspension 
group 
Use C57BU6 wild -type mice (N=40 total) 
mi RNA-Seq 
5 Gy 137Cesium Gamma-Rays 
i,, i,, i,, \ 
,, 
ddPCR 

















0 Negative Impact on Health 
0 Positive Im pact on Health 
O Both Pos itive and 
Negative Impact 
COLUMBIA UNIVERSITY 
IRVING MEDICAL CENTER 
l sooo I:::: ~ .,,,., I 
~ 2000 
E 
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Sham None 0.0 Gy
Sham + HU None 0.0 Gy
Gamma Gamma 5.0 Gy
Gamma + HU Gamma 5.0 Gy
SPE SPE 1.0 Gy
SPE + HU SPE 1.0 Gy
GCR Sim GCR Sim 0.5 Gy
GCR Sim + HU GCR Sim 0.5 Gy








Proton 1000 0.2 175 0.35
28Si 600 50.4 5 0.01
4He 250 1.6 90 0.18
16O 350 20.9 30 0.06
56Fe 600 173.8 5 0.01
Proton 250 0.4 195 0.39
















Hindlimb Unloaded (HU) Mice
Mice Irradiated at NSRL at BNL
Thanks to Adam Rusek, Peter Guida, 
Mike Sivertz, BLAF, and NSRL!!!
They’re still smiling after our BNL 





Total of N=10 mice 
per control group 
Collect Blood 
0.5Gy GCR Sim Model 
f'~dPCR ½, ½, ½, ½, 
Total of N=10 mice per 
hindl imb suspension 
group 
Use C57BU6 wild-type mice (N=40 total) 










mi RNA-Seq ddPCR 
All weights normalized 
to total body weight
Weights of Organs 24 hours after Irradiation
~35% increase in weight!
Gamma HU vs Sham NL 
SPE HU vs Sham NL 
GCR HU vs Sham NL 
0.2 
Heart 
p-values compared to Sham NL 
*** p-value < 0.001 
Normalized Weight Fold 
Gamma: HU vs NL 
SPE: HU vs NL 
GCR: HU vs NL 




p-values compared to NL 
** p-value < 0.01 
*** p-value < 0.001 






-1.5 -1.0 -0.5 0.0 







• Total of 320 samples for 
miRNA-sequencing
Samples that were miRNA-sequenced
All miRNA-seq data will be 
deposited on GeneLab after 
first publication!!
Total of N=10 mice 
per control group 
Collect Blood 
0.5Gy GCR Sim Model 
')dPCR ¼, ¼, ¼, ¼, 
Total of N=10 mice per 
hindlimb suspension 
group 
Use C57BU6 wild-type mice (N=40 total) 
1Gy SPE Sim 5 Gy 137Cesium Gamma-Rays 
¼,¼i ¼,¼, ¼,¼i ¼,¼, 
C57BU6 mice unler Hindlimb Suspension (N=40 total) 
Afshin Beheshti 6-month Closeout
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t-SNE Dimension 1 
mi RNA-seq 
Heart 
Type of Loading 
0 HU 












0.5Gy GCR Sim 
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•. .In a vacuum. 
bastard theoretical physicists 






Human miRNAs Mouse miRNAs
Global View of miRNAs
In the miRNA world this 
depiction is great!!
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Statistics of Pathway Enrichment 
Toxoplasmosis - • 
Rheumatoid arthritis - • 
Pyruvate metabolism -
Porphyrin and chlorophyll metabolism -
Peroxisome -
Olfactory transduction - • 
Legionellosis -
Inflammatory bowel disease (IBD)-
Glycosphingolipid biosynthesis - lacto and neolact -













Statistics of GO Enrichment 
transferase activity - • 
sensory perception of smell - • 
protein transport - • 
protein binding - • 
plasma membrane - • 
oxidoreductase activity - • 
oxidation-reduction process - • 
olfactory receptor activity - • 
nucleotide binding - • 
mitochondrion -
membrane - • 
ral component of membrane - • 
hydrolase activity - • 
Golgi membrane -
Golgi apparatus - • 
plasmic reticulum membrane - • 
endoplasmic reticulum - • 
stimulus involved in sensory - • 
cytosol - • 
cytoplasm - • 


















Impact on Small Molecules
Gene Ontology
KEGG
Top 20 Genes Functions
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anatomical structure fonmation 




















Additional data that is being generated by Collaborators from other tissues: Initial 


























































































































































































































































































































































































Sham GCR SPE Gamma
* * * *













































































• Differential immune 
Profiles generated w/ 
different IR treatment
• GCR and SPE target 
lymphocytes (T cells in 






did not affect Tc or Th
populations  
• SPE and GCR did not 
affect innate system 
(non-proliferating/ 
terminally 
differentiated cells) as 
much as adaptive 
immune system 
(proliferating cells)
NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU
NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU NL  HU
Significance p <0.05 
& t-test 







Paladini et al. Journal of Expmmemol & Q1nic.ol ( oncer Research (2016) 3S:103 
001 10.1186/s13046-016-037S·2 Journal of Experimental & 
Clinical Cancer Research 
Table 1 MicroRNAs involved in Innate and Adapt ive Immune System Funct ions REVIEW Open Access 










let-7e•, miR-29a, miR-99b•, miR-125a, miR-126, miR-212/132 cluster 
miR-10 family, miR-126, miR-196b, miR-221/222 
Targeting microRNAs as key modulators of 
tumor immune response 
Laura Paladini', Linda Fabros', Giuha Bottai1, Glrlotta Raschoorli' , George A Gllin' ' and Libero 
Common myeloid progenitors Cell development miR-17, miR-24, miR-126, miR-128, miR-155, miR-18la 
Common lymphoid progenitors Cell development miR-126, miR-128, miR-146, miR-l 8la 
Granulocyte--macrophage progenitors Cell development miR-16, miR-103, miR-107 



















miR-223 nvolved in Innate and Adapt ive Immune System Functions (Continued) 
miR-155, miR-221/222 Cell activation miR-155, miR-18la, miR-182, miR-214 
miR-1 0a/b, miR-17, miR-20, miR-126 T helper cel ls Cell differentiation miR-125b, miR-150 
Cell differentiation miR-17-Sp, miR-20a, miR-21, miR-106a, miR-155, miR-196b, miR-223, mi T helper 1 cells Cell differentiation miR-17/92 cluster, miR-29, miR-146a, miR-148a, miR-155, miR-210, miR-326 
Cell activation miR-155, miR-424 
Cell differentiation miR-21, miR-34a Cell function miR-155 
Cell function miR-l0a, miR-148/152, miR-155, miR-223 T cytotoxic eel Is Cell differentiation Let-7f, miR-15b, miR-16, miR-17/92 cluster, miR-21, miR-139, miR-142, miR-150, miR-155, mi 
Cell differentiation miR-1 Sa, miR-16, miR-19a-3p, miR-21 , miR-107, miR-146a, miR-424 Cell function miR-17/92 cluster, miR-21 , miR-29, miR-23a, miR-24, miR-27a, miR-30b, miR-130/301 , m 
Cell function Let-7, miR-9, miR-21 , miR-101, miR-125b, miR-146a, miR-147, miR-155, --------=====----::-----m_i_R-_1_so_,_m_i_R_-1_s_s_, m_ iR_-2_1_4 ___________________ _ 
miR-378, miR-487b, miR-1 224 T regulatory cells Cell differentiation miR-17/92 cluster, miR-10, miR-99a/miR-l 50, miR-155 
Cell polarization let-7c, let-7f, miR-9, miR-21, miR-33, miR-101, miR-124, miR-125, miR-146, Cell function miR-142-3p, miR-146a, miR-155 
Cell differentiation miR-1 Sa, miR-21, miR-27, miR-l 96b, miR-223 
Cell function miR-223 
T helper 17 cells 
T follicu lar helper cells 
Cell differentiation miR-l0a, miR-19b, miR-17, miR-155, miR-210, miR-212/ 132 cluster, miR-301, miR-326 
Cell differentiation miR-l0a, miR-17/92 cluster 
Cell function miR-223 
s are in bold. MDSCs, Myeloid-Derived Suppressor Cells 
! required 
Cell function miR-494, miR-17-5p/20a 
Cell differentiation miR-l0a, miR-l 30a, miR-146a, miR-150, miR-155, miR-223 
Cell differentiation miR-15a, miR-16, miR-24, miR-144, miR-150, miR-155, miR-221/222 cluster, miR-223, miR-451 
Cell differentiation miR-150, miR-181a/b 
Cell function miR-15/16, miR-27a, miR-29, miR-30c- l, miR-30e, miR-155, miR-223, miR-378 
Cell differentiation miR-17/ 92 cluster, miR-23a, miR-34a, miR-142, miR-150, miR-155, miR-181 family, miR-212/132 cluster 
Cell activation miR-9, miR-17/ 92 cluster, miR-30, miR-l 25b, miR-155, miR-181b, miR-223 
Cell differentiation miR-148a 
Cell differenti tion miR-17/92 cluster, miR-21, miR-142-3p, miR-150, miR-181a, miR-223 
Current On-Going Work and What to Expect to See Soon!
• More analysis on the miRNA-seq data
– More Analysis on the GCR specific data
– SPE specific analysis
– Gamma specific analysis
– Hindlimb unloading specific analysis
• Countermeasure experiments
– Use antagomirs to potentially mitigate radiation 
effects
Peter Grabham
Utilize 3D microvascular tissue models to determine
functional impact of miRNAs and start development of
miRNA based countermeasures.
• Irradiated 3D tissue model with 1Gy SPE sim
• Irradiated 3D tissue model with 0.5Gy GCR sim model with and 
without 3 antagomir countermeasure
• Promising results so far and more experiments and results to 
come soon!
Robert Meller
• Complementary results on Deep RNA-sequencing 
on the whole blood
– Rob Meller is providing and analyzing 
complementary results on deep sequencing on 
the whole blood from these mice
• Predicted Activation 
• Predicted Inhibition 
0 Negative Impact on Health 
0 Positive Impact on Health 
Both Positive and 
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David Kaplan Laura Chambre
• Their team is assisting with designing a silk based drug 
delivery system to apply miRNA antagonists for 
countermeasures
• We are planning on testing the silk based antagomir capsules 
in the BNL spring run both in mice and the 3D tissue model
Images obtained from https://sackler.tufts.edu/facultyResearch/faculty/kaplan-david/research
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Peter Grabham
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miRNA Research will Further Assist with NASA’s Future Missions
HUMAN EXPLORATION 
NASA's Path to Mars 
RETURN TO EARTH: HOURS 
Mastering fundamentals 
aboard the International 
Space Station 
U.S. companies 
provide access to 
low-Earth orbit 
www. nasa.gov 
RETURN TO EARTH: DAYS 
Expanding capabilities by 
visiting an asteroid redirected 
to a lunar distant retrograde orbit 
,,.,,.. 
The next step: traveling beyond low-Earth~ ,,..., 
orbit with the Space Launch System ....- · 
rocket and Orion spacecraft \ 
~- ;~{,S READY 
11 ;_ f\ f: C i L_ / -. I 1..) 
RETURN TO EARTH: MONTHS 
Developing planetary independence 
by exploring Mars, its moons and 
other deep space destinations 
Theme Strategic Goal 
EXPAND HUMAN KNOWLEDGE 
THROUGH NEW SCIENTIFIC 
DISCOVERIES. 
EXTEND HUMAN PRESENCE 
DEEPER INTO SPACE AND TO 
EXPLORE THE MOON FOR SUSTAINABLE 
LONG-TERM EXPLORATION AND 
UTILIZATION. 
ADDRESS NATIONAL 
DEVELOP CHALLENGES AND CATALYZE 
ECONOMIC GROWTH. 
OPTIMIZE CAPABILITIES AND 
OPERATIONS. 
EXPAND HUMAN KNOWLEDGE THROUGH NEW 
SCIENTIFIC DISCOVERIES. 
EXTEND HUMAN PRESENCE DEEPER INTO SPACE 
AND TO THE MOON FOR SUSTAINABLE LONG-
TERM EXPLORATION AND UTILIZATION 
~J ADDRESS NATIONAL CHALLENGES AND 
., CATALYZE ECONOMIC GROWTH. 
~ OPTIMIZE CAPABILITIES AND OPERATIONS. , 
Strategic Objective 
1.2· Underntand Responses of Physical and Biological Systems to 
Spaceflight. 
2. 1· Lay the Foundation for Amenca to Maintain a Constant Human 
Presence in Low Earth Orbit Enallloo by a Cornroorcial Market. 
2 2: Conduct Exploration in Deep Space, Including to the Surface r:J the 
Moon. 
3.1. Develop and T ranster Revolutionary T echnotogies to Enable 
Exploration Capabilnies for NASA and the Nation. 
3 2: Transtonm AviatKln Through RevolutKJnary Technology Research, 
Development, and Transfer. 
3 3: lnspre and Engage the Public in Aeronautics, Space, and Science 
4. 1" Engage in Partnership Strategies 
4.2: Enable Space f,,,x;ess and Serv,ces 
4.3. Assure Safety and Mission Success. 
4.4: Manage Human Gaprtal. 
4.5· Ensure Enterprise Protection 
4.6· Sustain lnfrastrucltxe Gapabifrties and Operations 
Overall Conclusion with miRNA studies
• Can apply similar techniques for 
majority of diseases to determine 
circulating miRNA signature 
associated with each disease for 
liquid biomarker!
• Also can use similar techniques to 
inhibit the circulating miRNA 
signature
• OPEN FOR COLLABORATIONS!!
Ga)'O N£WSl, l(ovR 1ESf 
f tJ~\GATE! TKA, You'(lf 




Thanks to Systems 
Biology, we now have 
a clear picture of 
complex diseases! 
